Brookfield Corp (BN) stock

BNNYSEOpeators of Nonresidential BuildingsFiscal year ends December 31Also trades as BAMGF, BAMKF, BKAMF, BKFAF, BKFDF, BKFOF, BNH, BNJ, BRCFF, BRFAF, BRFCF, BROXF, BRPSF, BXDIF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 40-F on Mar 18, 2026Score 3/30

$40.97−0.67 (-1.61%)

Close on Nov 13, 2026Market cap $61.89BP/E 83.6Yield –

Brookfield r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Brookfield

Brookfield has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Where these numbers come from

Parsed from the XBRL in Brookfield's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-2 split on Mar 18, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BN.

Compare: BN vs CBRE · BN vs BPYPM · BN vs ENB · BN vs RNW · BN vs BIP

Revenue growth-12.7% · median 27.4%

Net margin1.7% · median 5.3%

Company	Revenue	Growth
ENB	C$89.93B	+40.0%
BN	$75.10B	-12.7%
CBRE	$45.01B	+14.8%
BPYPM	–	–
RNW	–	–
BIP	–	–

Company

Exchange: NYSE
Industry: Opeators of Nonresidential Buildings
Fiscal year ends: December 31
Auditor: Deloitte LLP
SEC CIK: 1001085

Advertisement
300 × 250

See a number that looks wrong?

Brookfield r&d expenses

No r&d expenses figures for Brookfield

More Brookfield figures